REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue
Clinical trial NCT04525183 · COMPLETED
Trial details
- NCT number
- NCT04525183
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-02
- Primary completion
- 2022-08-09
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.